申请人:Global Blood Therapeutics, Inc.
公开号:US20200157085A1
公开(公告)日:2020-05-21
The present disclosure relates generally to compounds and pharmaceutical compositions suitable as modulators of hemoglobin, and methods for their use in treating disorders mediated by hemoglobin.
本公开涉及一般与血红蛋白调节剂相关的化合物和药物组合物,以及它们在治疗由血红蛋白介导的疾病中的使用方法。